It is a trading private limited company based in Chennai, Tamil Nadu, India, established in 2013.
2013 | Chennai, Tamil Nadu, India | ActiveSri Murali Pharmaceuticals Private Limited, a active private limited company, was established on 14 October 2013 in Chennai, Tamil Nadu, India. Engaging in retail trading within the trade sector, it holds CIN: U52300TN2013PTC093329. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Jayaraman Balaraman (Director), Indumathy (Director). Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at No.7/46, North Avenue Road, Muthamizh Nagar, Kodungaiyur, Chennai, Tamil Nadu, 600118.
U52300TN2013PTC093329
093329
14 October 2013
₹0.10 M
₹0.10 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Sri Murali Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jayaraman Balaraman | Director | 14 Oct 2013 | Current |
| Indumathy | Director | 14 Oct 2013 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sri Murali Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 77.17% increase. The company also saw a substantial improvement in profitability, with a 113.86% increase in profit. The company's net worth Soared by an impressive increase of 12.72%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Sri Murali Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sri Murali Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sri Murali Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Murali Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sri Murali Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was recorded as a recent event.
The activity Sri Murali Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Chennai. was completed.
The activity Jayaraman Balaraman was appointed as a Director was appointed as a Director on 14 Oct 2013 & has been associated with this company since 12 years 2 months . was completed.
Indumathy was appointed as a Director was appointed as a Director on 14 Oct 2013 & has been associated with this company since 12 years 2 months . was recorded as a recent event.
The activity Sri Murali Pharmaceuticals Private Limited was registered on 14 Oct 2013 with Roc Chennai & aged 12 years 2 months as per MCA records. was completed.
The CIN of Sri Murali Pharmaceuticals Private Limited is U52300TN2013PTC093329.
Sri Murali Pharmaceuticals Private Limited is headquartered at No.7/46, North Avenue Road, Muthamizh Nagar, Kodungaiyur, Chennai, Tamil Nadu, 600118.
Sri Murali Pharmaceuticals Private Limited was incorporated on 14 October 2013.
The current directors of Sri Murali Pharmaceuticals Private Limited are
The primary industry of Sri Murali Pharmaceuticals Private Limited is Trade.
Sri Murali Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sri Murali Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sri Murali Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX